Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

被引:0
作者
Childress, Ann [1 ]
Cutler, Andrew [2 ]
Gasior, Maria [3 ]
Hamdani, Mohamed [3 ]
Ferreira-Cornwell, M. Celeste [3 ]
Squires, Liza [3 ]
Findling, Robert [4 ]
机构
[1] Ctr Psychiat & Behav Med, Las Vegas, NV USA
[2] Florida Clin Res Ctr LLC, Bradenton, FL USA
[3] Shire Dev Inc, Wayne, PA USA
[4] Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA
关键词
DEFICIT/HYPERACTIVITY DISORDER;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:533 / 533
页数:1
相关论文
共 2 条
[1]   Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder [J].
Adler, Lenard A. ;
Goodman, David W. ;
Kollins, Scott H. ;
Weisler, Richard H. ;
Krishnan, Suma ;
Zhang, Yuxin ;
Biederman, Joseph .
JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (09) :1364-+
[2]   Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study [J].
Biederman, Joseph ;
Krishnan, Suma ;
Zhang, Yuxin ;
McGough, James J. ;
Findling, Robert L. .
CLINICAL THERAPEUTICS, 2007, 29 (03) :450-463